Dr. Julia Glade Bender is a Full Member (Professor), Vice Chairman for Pediatric Clinical Research and co- Medical Director of the Lisa and Scott Stuart Center for Adolescent and Young Adult (AYA) Cancer at Memorial Sloan Kettering Cancer Center (MSK).
A graduate of Yale University and the University of Pennsylvania School of Medicine, Dr. Glade Bender completed her pediatric residency at the Mount Sinai Hospital and her pediatric hematology-oncology fellowship at MSK, both in New York City. Her clinical research has focused on the development of targeted agents for children and AYA with advanced solid tumors and the identification of biomarkers predictive of response.
Dr. Glade Bender has provided broad scientific leadership for early phase clinical trial development sponsored by the National Cancer Institute (NCI), the Children’s Oncology Group (COG), as well as smaller disease-oriented consortia and pharmaceutical industry chairing or vice chairing more than 15 national trials. She serves as consultant to the Pediatric Oncologic Drugs Advisory Committee (ODAC) of the Food and Drug Administration (FDA) and sits on multiple philanthropic boards as a Scientific Advisor including The Saint Baldrick’s Foundation and the Fight Kids Cancer Programme.
